Adenocarcinoma of LungGene Expression ProfilingHepatitis A Virus Cellular Receptor 2
Dr. Scott M. Lippman, MD
NPI1780780874
- Publications
- 335
- Clinical trials
- 7
- Industry payments
- $1,203
- Insurance carriers
- 14
- State licenses
- 3
- Practice address
- 200 W Arbor Dr, San Diego, CA 92103
- Practice phone
- Call (713) 792-6161
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Lippman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Scott M. Lippman is a medical oncologist in San Diego, California
Dr. Lippman practices in San Diego, California.
Dr. Lippman's NPI, 1780780874, was assigned on September 15, 2006. Dr. Lippman graduated from The Johns Hopkins University School of Medicine in 1981. Dr. Lippman's Texas license number on file is H4987.
NPI and contact details
- NPI
- 1780780874NPI Registry (opens in a new tab)
- NPI enumeration date
- September 15, 2006
- NPI status
- Active
- Practice phone
- (713) 792-6161
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Scott M. Lippman's practice address is in San Diego, California
Dr. Lippman's practice address in the NPI Registry is 200 W Arbor Dr, San Diego, CA 92103, in San Diego County. The practice phone is (713) 792-6161.
- NPI Registry address200 W Arbor Dr, San Diego, CA 92103 · San Diego CountyPhone(713) 792-6161
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Scott M. Lippman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lippman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Lippman's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Lippman practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Scott M. Lippman is one of 415 medical oncologists in California
Medical oncology is Dr. Lippman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lippman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lippman's licenses on file in 3 states: Texas, Arizona and California.
Specialties and state licenses
- Medical oncology, TexasPrimary
- Arizona license
- California license
Clinical focus
Dmand AI lists lung cancer among the conditions Dr. Lippman treats.
Medical oncologists near Dr. Lippman
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Scott M. Lippman's patients have a median age of 62
Across all payers, Dmand AI patient panel data puts Dr. Lippman's median patient age at 62, with 100% women.
Dr. Lippman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 62
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. Scott M. Lippman has 335 publications on record
Dmand AI links 335 papers to Dr. Lippman, published from 2003 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Lung Neoplasms. Dr. Lippman has published most often in Clin Cancer Res. Dr. Lippman's most frequent co-authors are Adel K. El-Naggar, MD, PhD, Ian M. Thompson, MD and Gary Lee Clayman, DMD, MD.
Papers335
Years published2003 to 2025
Dr. Lippman's papers by year, 2016 to 2025
Topics Dr. Lippman writes about most
- Carcinoma, Squamous Cell
- Head and Neck Neoplasms
- Lung Neoplasms
- Prostatic Neoplasms
- Biomarkers, Tumor
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Isotretinoin
Dr. Lippman's most frequent co-authors
- Adel K. El-Naggar, MD, PhD32 shared papers
- Ian M. Thompson, MD28 shared papers
- Gary Lee Clayman, DMD, MD25 shared papers
Recent publications by Dr. Lippman
Cytokine Growth Factor Rev
Antibodies, Monoclonal, HumanizedArthritis, RheumatoidCommunicable Diseases
Cell Transformation, NeoplasticPrecancerous Conditions
See who Dr. Lippman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lippman works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Scott M. Lippman has worked on 7 clinical trials
Dmand AI links Dr. Lippman to 7 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Erythroplasia. National Cancer Institute (NCI) sponsors the most, 3.
Clinical trials with Dr. Lippman by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 3Phase 2: 3 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Lippman's trials
- Prostatic Neoplasms
- Prostatic Diseases
- Erythroplasia
- Mouth Neoplasms
- Smoking
Investigators on the most trials with Dr. Lippman
- Gary Lee Clayman, DMD, MD1 shared trial
- Ezra E. Cohen, MD1 shared trial
- Elward David Crawford, MD1 shared trial
Recent clinical trials with Dr. Lippman
Histology-Independent Study of Palbociclib in Patients With Advanced Cancer (opens in a new tab)
WithdrawnPhase 2
Palbociclib 125mg
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion (opens in a new tab)
Active, not recruitingPhase 2
ErythroplasiaLeukoplakia, OralMetformin Hydrochloride
Erlotinib Prevention of Oral Cancer (EPOC) (opens in a new tab)
CompletedPhase 3
Mouth NeoplasmsCarcinoma in SituErlotinib
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer (opens in a new tab)
CompletedPhase 2
SmokingSmall Cell Lung CarcinomaBudesonide
Prostatic NeoplasmsProstatic Diseases
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Scott M. Lippman received $1,203 in industry payments in 2016
CMS Open Payments shows 6 general payments to Dr. Lippman from 2 drug and device companies in 2016. Travel and lodging make up the largest share, 70% of the total. Masimo Corporation paid the most, $1,035.
General payments to Dr. Lippman by kind, 2016 to 2016
$1.2Kin total
- Travel and lodging$83970%
- Food and beverage$36530%
Companies that paid Dr. Lippman the most, 2016 to 2016
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Scott M. Lippman has 4 awards and honors on record
Dmand AI lists 4 awards for Dr. Lippman, most recently Super Doc in 2009.
Awards and honors for Dr. Lippman
- 2009
- Super Doc
- Undated
- ASCO Fellow
- Association of American Physicians
- Whos Who
Source: Dmand AI Professional Profile Data
Dr. Scott M. Lippman graduated from The Johns Hopkins University School of Medicine
Dr. Lippman graduated from The Johns Hopkins University School of Medicine in 1981. Dr. Lippman is a member of AACR and ASCO.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Scott M. Lippman accepts plans from 14 insurance carriers
Dr. Lippman is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Elevance
- Blue Cross Blue Shield of Michigan
- United Healthcare
- HCSC
- Humana
- Aetna
- Blue Cross Blue Shield of Massachusetts
- Molina
- +6 more carriersWith a free account
Plan types Dr. Lippman accepts, by number of carriers
- PPO10
- HMO8
- Medicare8
- EPO3
- POS3
Source: Dmand AI Insurance Network Data
Sources for Dr. Scott M. Lippman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Scott M. Lippman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Scott M. Lippman's NPI number?
Dr. Scott M. Lippman's NPI number is 1780780874. It was assigned on September 15, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Scott M. Lippman?
Dr. Scott M. Lippman is a medical oncologist in San Diego, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Scott M. Lippman practice?
Dr. Lippman practices at 200 W Arbor Dr, San Diego, CA 92103.
What is Dr. Scott M. Lippman's office phone number?
The practice phone on file for Dr. Lippman is (713) 792-6161.
What is Dr. Scott M. Lippman's medical license number?
Dr. Lippman's Texas license number on file is H4987, one of the licenses on file in 3 states.
Which states has Dr. Scott M. Lippman been licensed in?
Dmand AI has state licenses on file for Dr. Lippman in Texas (1988 to 2013), Arizona (1987 to 2027) and California (1981 to 2027).
Is Dr. Scott M. Lippman board certified?
Yes. Dr. Lippman is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. Scott M. Lippman go to medical school?
Dr. Lippman graduated from The Johns Hopkins University School of Medicine in 1981.
Has Dr. Scott M. Lippman received payments from drug or device companies?
CMS Open Payments shows $1,203 in general payments to Dr. Lippman from 2 companies from 2016 to 2016. The largest total came from Masimo Corporation.
How long has Dr. Scott M. Lippman been practicing?
Dr. Lippman graduated from medical school in 1981, 45 years ago.
Show 3 more questionsShow fewer questions
Does Dr. Scott M. Lippman do research?
Dmand AI links 335 publications to Dr. Lippman, published from 2003 to 2025. Dr. Lippman has worked on 7 clinical trials.
Who does Dr. Scott M. Lippman publish with?
Dr. Lippman's most frequent co-authors are Adel K. El-Naggar, MD, PhD (32 shared papers), Ian M. Thompson, MD (28 shared papers) and Gary Lee Clayman, DMD, MD (25 shared papers).
What insurance does Dr. Scott M. Lippman accept?
Dr. Lippman is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card